These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37715436)

  • 41. Carotid endarterectomy and intracranial thrombolysis: simultaneous and staged procedures in ischemic stroke.
    Eckstein HH; Schumacher H; Dörfler A; Forsting M; Jansen O; Ringleb P; Allenberg JR
    J Vasc Surg; 1999 Mar; 29(3):459-71. PubMed ID: 10069910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke.
    Cheng XD; Wang DZ; Zhang Q; Wang JH; Li BH; Zhang X; Zhang J; Zhou S; Jia LJ; Wang LR; Yu NW
    BMC Neurol; 2023 Jun; 23(1):244. PubMed ID: 37353783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application of quantitative electroencephalogram monitoring in evaluating thrombolytic effect of acute cerebral infarction].
    Jin L; Wang Y; Lyu Z; Zhang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):207-210. PubMed ID: 33729141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke.
    Ueda T; Sakaki S; Kumon Y; Ohta S
    Stroke; 1999 Nov; 30(11):2360-5. PubMed ID: 10548671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of alteplase intravenous thrombolysis combined with butylphthalide in patients with acute severe cerebral infarction.
    Wang Z; Che J
    Folia Neuropathol; 2022; 60(4):421-426. PubMed ID: 36734384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator.
    Liu SY; Cao WF; Wu LF; Xiang ZB; Liu SM; Liu HY; Pan Y; Nie F; Wu XM; Xie XF
    Medicine (Baltimore); 2018 Dec; 97(49):e13216. PubMed ID: 30544380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Murray V; Berge E; Del Zoppo GJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000213. PubMed ID: 19821269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit.
    Wiegand N; Lüthy R; Vogel B; Straumann E; Beynon C; Bertel O; Oelz O; Caspar CB
    Swiss Med Wkly; 2004 Jan; 134(1-2):14-7. PubMed ID: 14745662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic analysis of different therapeutic regimens in patients with acute cardiogenic cerebral embolism.
    Hu L; Duan G; Xu Y; Cao Y
    BMC Neurol; 2021 Aug; 21(1):325. PubMed ID: 34425782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Value of Diffusion-Weighted Imaging (DWI) Apparent Diffusion Coefficient (ADC) in Patients with Hyperacute Cerebral Infarction Receiving rt-PA Intravenous Thrombolytic Therapy.
    Sui HJ; Yan CG; Zhao ZG; Bai QK
    Med Sci Monit; 2016 Nov; 22():4438-4445. PubMed ID: 27864581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of standardized nursing cooperation on intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke.
    Yin C; Qi L; Jing X
    Am J Transl Res; 2021; 13(10):11925-11931. PubMed ID: 34786123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients.
    Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL
    Cell Biochem Biophys; 2015 Jul; 72(3):883-8. PubMed ID: 27352190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.